IE 11 is not supported. For an optimal experience visit our site on another browser.

Shares of Pluristem Therapeutics to be Included in Mid Cap 50 TA Index on the Tel Aviv Stock Exchange (TASE) Beginning June 15, 2011

/ Source: GlobeNewswire

HAIFA, Israel, June 13, 2011 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR) today announced that according to the TASE announcement, its ordinary shares will be added to the Mid-Cap-50 Index on the TASE, beginning on June 15, 2011. The Mid-Cap-50 Index includes the 50 shares with the highest market capitalization that are not included in the TA-100 index.

Following the inclusion in the Mid-Cap-50 the company's ordinary shares will be included in the following TASE equity indexes: Biomed Index, Mid-Cap-50 TA Index, TA BlueTech-50 Index, TA Composite Index, Shares Index and the Industry Index. 

About Pluistem Therapeutics Inc.

For more information about Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR) visit , the content of which is not part of this press release. Follow Pluristem on Twitter @Pluristem.

The Pluristem Therapeutics Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6882

CONTACT: Pluristem Therapeutics Inc. William Prather R.Ph., M.D., Sr. VP Corporate Development 1-303-883-4954 William.PratherMD@pluristem.com Daya Lettvin Director Investor & Media Relations +972-54-674-5580 daya@pluristem.com Media Contact: Matthew Krieger Ruder Finn - for Pluristem +972-54-467-6950 matthew@ruderfinn.co.il